Correction to “Dual‐Action Psoriasis Therapy: Antiproliferative and Immunomodulatory Effects via Self‐Locking Microneedles”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Advanced Drug Delivery Systems
Adv Sci. 2024;11(48):e2409359.
- 1)In Figure 3g, the images of “Cy5.5 (Cal replacement drug)” at 30min and 1h were placed in the wrong sequence. In addition, the 6h image was incorrectly replaced by the 4h image. We tracked down the original data and have replaced it with the correct image as follows:
Figure 3. Characterization of mechanical embedding and encapsulation properties of Deu@Cal MNs. a) In vitro microneedle morphological and structural changes in a high‐humidity environment (Scale bar: 1 mm). b) OCT imaging of the structural changes of microneedle puncture into the subcutaneous skin of mice (Scale bar: 2mm, 500 µm). c) Changes in the recovery of Deu@Cal MNs insertion sites on the skin surface of mice. d) Schematic illustration of mechanical embedding and e) evaluation of adhesion force of Deu@Cal MNs. f) Change in skin surface moisture before and after MNs treatment. g) Representative in vivo fluorescence images of mice at different time points after administration of the respective simulated fluorescent drugs. h) Relationship between mean square displacement and time for Cy3 (substitute for Deu) and Cy5.5 (substitute for Cal) (n = 3).
- 2)In Figure S4 (Supporting Information), the images of “Cy5.5” at 4 and 6h were placed in the wrong sequence. We tracked down the original data and have replaced the correct image as follows:
Figure S4. In vivo fluorescence images of mice at different time points after administration of the respective simulated fluorescent drugs. (Cy3 as Deu replacement drug and Cy5.5 as Cal replacement drug, n = 3).
Figure S8 (Supporting Information), the images in the second row, corresponding to Cal 1 × 10^−^⁹ mol L^−1^, were inadvertently replaced with images from the Control group. We tracked down the original data and have replaced it with the correct image as follows:
Figure S8. Relative viability of HaCaT cells incubated with extracts of various concentrations of Cal MNs after 24 h (scale bar: 100 µm).
These errors do not affect the results or conclusions of the paper.
We apologize for this error.